BioSpace News Archive

Biovica, active in cancer diagnostics, announced that the scientific journal Clinical Cancer Research has published data from the TREnd study, demonstrating the benefits of using DiviTum® when evaluating palbociclib treatment outcome in women with metastatic breast cancer.

Technavio has announced its latest market research report titled global vascular embolization devices market 2020-2024.

Healthcare companies and philanthropies to fund training of thousands of community health workers as part of larger initiative led by Last Mile Health and Living Goods to advance universal health coverage

Dr. Christopher Otiko, President of ViaDerma, stated “Having this line of credit in place gives us the ability to fulfill all future orders and frees us up to focus completely on finalizing several pending sales agreements.”.

Children are twice as likely as adults to experience a dog bite in the eye area, and public health measures should warn against children being at eye level with dogs, even those that are familiar and under adult supervision, according to a new study.

Technavio has announced its latest market research report titled global dental 3D printing devices market 2019-2023.

Company Receives FDA Guidance for Pivotal Trial Design in Follicular Lymphoma to Support Accelerated and Full Approval

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) will release its fourth-quarter and full-year 2019 financial results on Wednesday, Feb. 19, 2020. Bausch Health will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update.

LUNGevity has issued a Request for Applications (RFA) for translational research for Career Development Awards that will be granted in 2020.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biopharmaceutical company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced new findings in its collaboration with Univo Pharmaceuticals (TASE:UNVO) characterizing the effects of cannabinoids on diseases mediated through the A3 adenosine receptor (A3AR)